Eupraxia Pharmaceuticals (EPRX) Return on Capital Employed [ROCE] (2024 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Return on Capital Employed [ROCE] of -37.43% for the quarter ended Jun 30, 2026, up 84.56 percentage points from -121.99% a year earlier and up 3.59 percentage points from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals' Return on Capital Employed [ROCE] came in at -70.26%, up 37.27 percentage points from the prior year.
- In prior years, Eupraxia Pharmaceuticals' Return on Capital Employed [ROCE] was -107.53% in the year ended Dec 31, 2024 (+9288.78 pp) and -9396.31% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Return on Capital Employed [ROCE] in data going back to the quarter ended Jun 30, 2024.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +74.42 percentage points over the last five quarters.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -41.02% (quarter ended Mar 31, 2026), -46.14% (quarter ended Dec 31, 2025) and -54.30% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Eupraxia Pharmaceuticals | 289.28 Mn | 287.68 Mn | - | -37.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.43% |
| Mar 31, 2026 | -41.02% |
| Dec 31, 2025 | -46.14% |
| Sep 30, 2025 | -54.30% |
| Jun 30, 2025 | -121.99% |
| Mar 31, 2025 | -89.13% |
| Dec 31, 2024 | -134.76% |
| Sep 30, 2024 | -187.12% |
| Jun 30, 2024 | -139.98% |
API Access
Eupraxia Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();